Skip to main content
HairCited

米诺地尔(Minoxidil) 用于 斑秃

A

基于48项研究(2项荟萃分析、1项RCT),共21,842名参与者。37/48项研究显示积极效果。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

Minoxidil has strong evidence supporting its use for alopecia areata, with the majority of studies showing positive effects, and is widely used as both a topical and oral option for this condition.

  • 37 out of 48 studies show positive effects across a large pool of 21,842 participants
  • Available in topical (2% and 5%) and oral low-dose formulations
  • Extends the hair growth phase and increases blood supply to hair follicles
  • Often used in combination with other treatments like corticosteroids for enhanced effectiveness

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None 效果: None None

研究人群: women with androgenetic alopecia (female pattern hair loss)

Case Reports n=1
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case …
Dose: None vs: None Outcome: hair regrowth in severe alopecia areata 效果: None None

研究人群: patient with severe alopecia areata with suboptimal response to tofacitinib

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo 效果: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None vs: None Outcome: None 效果: None None

研究人群: None

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo 效果: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
retrospective cohort study n=321
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study.
Dose: Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi vs: Placebo 效果: 91.3% received definitive remote diagnosis; only 8.7% required in-person follow-up. AA most common ( None

Key Statistics

122

研究数量

27416

受试者

Positive

A

等级

Referenced Papers

Dermatologic clinics 2025 5 次引用
Pediatric dermatology 2025 5 次引用
Journal of the … 2025 2 次引用
International journal of … 2025 1 次引用
Journal of clinical … 2025 1 次引用
Archives of dermatological … 2025
International journal of … 2024 39 次引用
American family physician 2024 8 次引用
Skin health and … 2024 7 次引用
Journal of the … 2024 7 次引用
The Journal of … 2024 2 次引用
Archives of dermatological … 2023 16 次引用
The Cochrane database … 2023 2 次引用
The Journal of … 2022 170 次引用
Journal of the … 2022 90 次引用
Dermatology and therapy 2022 43 次引用
Skin appendage disorders 2022 7 次引用
The American Journal … 2022 2 次引用
Journal of dermatological … 2021 51 次引用
American journal of … 2020 127 次引用
International journal of … 2020 58 次引用
The journal of … 2020 3 次引用
The Australasian journal … 2019 152 次引用
American journal of … 2019 84 次引用
Journal of the … 2019 50 次引用
Expert opinion on … 2019 34 次引用
Klinicka onkologie : … 2019 11 次引用
Journal of the … 2018 114 次引用
Dermatology online journal 2018
American family physician 2017 141 次引用
American journal of … 2017 32 次引用
Actas dermo-sifiliograficas 2017 17 次引用
Deutsches Arzteblatt international 2016 99 次引用
Current problems in … 2015 322 次引用
The Medical clinics … 2015 66 次引用
Canadian family physician … 2015 31 次引用
The journal of … 2015 25 次引用
Current problems in … 2015 18 次引用
Der Internist 2015
Lasers in surgery … 2014 243 次引用
American journal of … 2014 82 次引用
Expert opinion on … 2014 57 次引用
Giornale italiano di … 2014 18 次引用
Giornale italiano di … 2014
International journal of … 2013 61 次引用
Recent patents on … 2011 6 次引用
Seminars in cutaneous … 2009 85 次引用
American family physician 2009
The Cochrane database … 2008 222 次引用
Current opinion in … 2008 31 次引用
International journal of … 2007 185 次引用
Alopecia areata. Case Report
Dermatology nursing 2007
The Australasian journal … 2006
Journal of the … 2005 44 次引用
Cleveland Clinic journal … 2005
Praxis 2003 28 次引用
American family physician 2003 2 次引用
American family physician 2003
American journal of … 2000 28 次引用
International journal of … 1999 16 次引用
Dermatologic clinics 1998 121 次引用
American family physician 1990
Dermatologic clinics 1987
Journal of the … 1984 122 次引用
Journal of the … 1984
Archives of dermatology 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

topical:
2-5% solution, twice daily

上限: 5% topical solution

研究中使用的剂量

剂量 持续时间 效果 N
None -- Neutral --
None -- Positive 1
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Mixed --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi -- Positive 321
None -- Mixed --
None -- Mixed 1

最佳服用时间: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

已报告的副作用

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

已知相互作用

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

可耐受最高摄入量: 5% topical solution

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does 米诺地尔(Minoxidil) help with 斑秃?
Based on 122 studies with 27,416 participants, there is strong evidence from multiple clinical trials that 米诺地尔(Minoxidil) may support 斑秃 management. Our evidence grade is A (Strong Evidence).
How much 米诺地尔(Minoxidil) should I take for 斑秃?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 米诺地尔(Minoxidil)?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 米诺地尔(Minoxidil) and 斑秃?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 122 peer-reviewed studies with 27,416 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。